These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28412324)

  • 1. Nanoformulation-based sequential combination cancer therapy.
    Shim G; Kim MG; Kim D; Park JY; Oh YK
    Adv Drug Deliv Rev; 2017 Jun; 115():57-81. PubMed ID: 28412324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoformulations for combination or cascade anticancer therapy.
    Miao L; Guo S; Lin CM; Liu Q; Huang L
    Adv Drug Deliv Rev; 2017 Jun; 115():3-22. PubMed ID: 28624477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
    Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
    Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer nanomedicine: from targeted delivery to combination therapy.
    Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
    Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release from nanocarriers: a review.
    Natarajan JV; Nugraha C; Ng XW; Venkatraman S
    J Control Release; 2014 Nov; 193():122-38. PubMed ID: 24862321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Based Combination Therapy for Cancer Treatment.
    Yhee JY; Son S; Lee H; Kim K
    Curr Pharm Des; 2015; 21(22):3158-66. PubMed ID: 26027570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antitumor therapy with targeted dual-nanomedicines.
    Dai W; Wang X; Song G; Liu T; He B; Zhang H; Wang X; Zhang Q
    Adv Drug Deliv Rev; 2017 Jun; 115():23-45. PubMed ID: 28285944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered nanoparticles for drug delivery in cancer therapy.
    Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanogel--an advanced drug delivery tool: Current and future.
    Sharma A; Garg T; Aman A; Panchal K; Sharma R; Kumar S; Markandeywar T
    Artif Cells Nanomed Biotechnol; 2016; 44(1):165-77. PubMed ID: 25053442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review.
    Dhadde SB; Patil JS; Chandakavathe BN; Thippeswamy BS; Kavatekar MG
    Crit Rev Ther Drug Carrier Syst; 2020; 37(5):407-434. PubMed ID: 33389846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.